Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT02754544
- Status
- Recruiting
Conditions
- Brain Neoplasm
- Metastatic Malignant Neoplasm in the Brain
- Recurrent Brain Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Direct Electrocortical Stimulation — PROCEDUREUndergo direct electrocortical stimulation
- Electrocorticography — OTHERUndergo electrocorticography
Study Details
This pilot clinical trial studies how well electrocorticography works in mapping functional brain areas during surgery in patients with brain tumors. Using a larger than the standard mapping grid currently used during brain tumor surgery or a high-definition grid for electrocorticogram brain mapping may help doctors to better identify which areas of the brain are active during specific limb movement and speech during surgery in patients with brain tumors.
Key Dates
- First listed
- Apr 28, 2016
- Start date
- Jul 22, 2016
- Status verified
- May 2026
- Primary completion
- Jan 1, 2027
- Completion
- Jan 1, 2028
Study Design
- Enrollment
- 75 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Diagnostic (electrocorticography)Patients undergo tumor resection. During surgery, patients also undergo electrocorticography with either the CorTec high resolution hybrid grid, the PMT high-resolution grid, or the Ad-Tech grid followed by direct electrocortical stimulation.
Primary Outcome Measure
Electrocorticogram (ECoG) [ Time Frame: Up to 6 months (± 4 weeks) ]
Central Contacts
- Sujit Prabhu, MD713-792-2400
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Sujit S. Prabhu (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPHASE3 · Recruiting · SWOG Cancer Research Network · Duarte, California
- Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-OncologyRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Tumor Related EpilepsyRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOAPHASE2 · Recruiting · Northwell Health · New York, New York